To investigate this, immunohistochemistry was performed on prostate cancer tissue microarrays and specimens scored for primary Gleason grade and for nuclear and cytoplasmic p23 staining on a scale of 0–3 (3 = highest intensity). This evidence concerns the gene PTGES3 and prostate carcinoma.